[1]
J. K. . Rogalski, A. . Subdys, and O. E. . Gawlik-Kotelnicka, “The development of the Metabolic-associated Fatty Liver Disease during pharmacotherapy of mental disorders – a review”, Curr Probl Psychiatry, vol. 23, no. 3, pp. 118–127, Oct. 2022, doi: 10.2478/cpp-2022-0013.